iSpecimen Inc. (ISPC) stock
Close on Nov 11, 2026Market cap $1.79MP/E –Yield –
iSpecimen Inc. saw revenue fall 92.1% to $466.30K over the twelve months to Jun 30, 2026. Free cash flow was -$4.24M. At the latest close the market valued the company at $1.79M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.79M
- P/E ratio
- –
- Price to sales
- 3.83
- Price to book
- 1.03
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $466.30K
- Net income
- -$11.42M
- EPS, diluted
- -$52.78
- Free cash flow
- -$4.24M
- Book value per share
- $1.25
- Diluted shares
- 1M
Trading
- Previous close
- $0.74
- Open
- $0.74
- Day's range
- $0.64 – $0.74
- Volume
- 96,374
- Average volume (20 days)
- 309,399
- Beta (5 years)
- 0.61
- 52-week range
- $0.64 – $27.44
- RSI (14 days)
- 27.8
- Volatility (1 year)
- 112.1%
- Relative volume
- 0.18×
- WACC
- 7.9%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ISPC | S&P 500 | Difference | ISPC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -37.2% | -2.4% | −34.8 pts | ||
| 3 months | -68.9% | -1.2% | −67.7 pts | ||
| Year to date | -93.2% | +12.3% | −105.5 pts | ||
| 1 year | -97.2% | +12.4% | −109.7 pts | ||
| 3 years | -99.8% | +78.8% | −178.6 pts | -88.0% | +21.4% |
| 5 years | -100.0% | +75.2% | −175.2 pts | -82.7% | +11.9% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases iSpecimen filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- News
- Update
About iSpecimen
Services-Commercial Physical & Biological Research
iSpecimen Inc. operates an online marketplace platform that connects life science researchers with healthcare provider organizations supplying human biospecimens, including biofluids, tissues, and living cells, along with associated clinical data. The platform harmonizes de-identified patient and specimen data from electronic medical records, laboratory information systems, and biobank inventory systems into a centralized dataset. This system enables researchers to search for specific cohorts, request quotes, configure custom collections, and place orders. The company serves clients across industry, academia, and government institutions.
Company profile, executives and historyiSpecimen stock: common questions
What is iSpecimen's stock price?
ISPC closed at $0.71 on Nov 11, 2026, down 3.81% on the day. Over the past 52 weeks it traded between $0.64 and $27.44.
What is iSpecimen's market cap?
iSpecimen was worth $1.79M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ISPC's P/E ratio?
iSpecimen lost money over the twelve months to Jun 30, 2026 (diluted EPS -$52.78), so it has no meaningful P/E ratio.
How much revenue does iSpecimen make?
iSpecimen reported revenue of $466.30K for the twelve months to Jun 30, 2026, down 92.1% from a year earlier.
Does iSpecimen pay a dividend?
No. iSpecimen has not paid a cash dividend over the last twelve months.
How has ISPC stock performed over the past year?
Including dividends, ISPC returned -97.2% over the past year, against +12.4% for the S&P 500.
How many ISPC shares are sold short?
0M shares were sold short at the latest FINRA report, 12.12% of the float, or 1.0 days of average trading volume.
Who are iSpecimen's competitors?
Companies most similar to iSpecimen by business, industry and size include ONMD, ABSI, CBIH, MWAI, AIDX.
See a number that looks wrong?